Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese population

Neuroscience Letters

Volumn 481, Issue 2, 2010, Pages 69-72

  Zuo, Xing ^a   Jiang, Hong ^a   Guo, Ji Feng ^a   Yu, Ren He ^a   Sun, Qi Ying ^a   Hu, Liang ^a   Wang, Lei ^a   Yao, Ling Yan ^a   Shen, Lu ^a   Pan, Qian ^b   Yan, Xin Xiang ^a   Xia, Kun ^b   Tang, Bei Sha ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b National Laboratory of Medical Genetics of China   (China)

Author keywords

Essential tremor; LINGO1 gene; Polymorphism; Sporadic Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; ESSENTIAL TREMOR; FEMALE; GENE; GENETIC SCREENING; HUMAN; LINGO1 GENE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77955281246     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.06.041     Document Type: Article

References (24)

1. Benito-Leon J., Louis E.D. Essential tremor: emerging views of a common disorder. Nat. Clin. Pract. Neurol. 2006, 2:666-678.
2. Białecka M., Kurzawski M., Tan E.K., Drozdzik M. Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis. Neurosci. Lett. 2010, 472:53-55.
3. Deng H, Le W., Jankovic J. Genetics of essential tremor. Brain 2007, 130:1456-1464.
4. Deuschl G., Bain P., Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov. Disord. 1998, 13:2-23.
5. Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., Marshall F.J., Ravina B.M., Schifitto G., Siderowf A., Tanner C.M. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007, 68:384-386.
6. Haubenberger D., Hotzy C., Pirker W., Katzenschlager R., Brucke T., Zimprich F., Auff E., Zimprich A. Role of LINGO1 polymorphisms in Parkinson's disease. Mov. Disord. 2009, 24:2404-2407.
7. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
8. Inoue H., Lin L., Lee X., Shao Z., Mendes S., Snodgrass-Belt P., Sweigard H., Engber T., Pepinsky B., Yang L., Beal M.F., Mi S., Isacson O. Inhibition of the leucine-rich repeat protein LINGO1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14430-14435.
9. Koller W.C., Busenbark K., Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann. Neurol. 1994, 35:717-723.
10. Louis E.D. Essential tremor. Lancet Neurol. 2005, 4:100-110.
11. Louis E.D., Bromley S.M., Jurewicz E.C., Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 2002, 59:1631-1633.
12. Louis E.D., Faust P.L., Vonsattel J-P.G., Honig L.S., Rajput A., Robinson C.A., Rajput A., Pahwa R., Lyons K.E., Ross G.W., Borden S., Moskowitz C.B., Lawton A., Hernandez N. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007, 130:3297-3307.
13. Louis E.D., Jurewicz E.C., Applegate L., Factor-Litvak P., Parides M., Andrews L., Slavkovich V., Graziano J.H., Carroll S., Todd A. Association between essential tremor and blood lead concentration. Environ. Health Perspect. 2003, 111:1707-1711.
14. Louis E.D., Zheng W., Applegate L., Shi L., Factor-Litvak P. Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 2005, 65:391-396.
15. Louis E.D., Zheng W., Jurewicz E.C., Watner D., Chen J., Factor-Litvak P., Parides M. Elevation of blood β-carboline alkaloids in essential tremor. Neurology 2002, 59:1940-1944.
16. Mi S., Sandrock A., Miller R.H. LINGO1 and its role in CNS repair. Int. J. Biochem. Cell Biol. 2008, 40:1971-1978.
17. Raethjen J., Deuschl G., Tremor Curr. Opin. Neurol. 2009, 22:400-405.
18. Rocca W.A., Bower J.H., Ahlskog J.E., Elbaz A., Grossardt B.R., McDonnell S.K., Schaid D.J., Maraganore D.M. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov. Disord. 2007, 22:1607-1614.
19. Stefansson H., Steinberg S., Petursson H., Gustafsson O., Gudjonsdottir I.H., Jonsdottir G.A., Palsson S.T., Jonsson T., Saemundsdottir J., Bjornsdottir G., Böttcher Y., Thorlacius T., Haubenberger D., Zimprich A., Auff E., Hotzy C., Testa C.M., Miyatake L.A., Rosen A.R., Kristleifsson K., Rye D., Asmus F., Schöls L., Dichgans M., Jakobsson F., Benedikz J., Thorsteinsdottir U., Gulcher J., Kong A., Stefansson K. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat. Genet. 2009, 41:277-279.
20. Tan E.K., Lee S.S., Fook-Chong S., Lum S.Y. Evidence of increased odds of essential tremor in Parkinson's disease. Mov. Disord. 2008, 23:993-997.
21. Tan E.K., Teo Y.Y., Prakash K.M., Li R., Lim H.Q., Angeles D., Tan L.C., Au W.L., Yih Y., Zhao Y. LINGO1 variant increases risk of familial essential tremor. Neurology 2009, 73:1161-1162.
22. Toulouse A., Sullivan A.M. Progress in Parkinson's disease-where do we stand?. Prog. Neurobiol. 2008, 85:376-392.
23. Vilariño-Güell C., Ross O.A., Wider C., Jasinska-Myga B., Cobb S.A., Soto-Ortolaza A.I., Kachergus J.M., Keeling B.H., Dachsel J.C., Melrose H.L., Behrouz B., Wszolek Z.K., Uitti R.J., Aasly J.O., Rajput A., Farrer M.J. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat. Disord. 2010, 16:109-111.
24. Wang L., Guo J.F., Nie L.L., Xu Q., Zuo X., Sun Q.Y., Yan X.X., Tang B.S. A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease. Neurosci. Lett. 2010, 468:198-201.